Prevention

Latest News

Stronger Recommendations by PCPs for Herpes Zoster Vaccination Needed

Stronger Recommendations by PCPs for Herpes Zoster Vaccination Needed

From January to March 2017, the researchers distributed a cross-sectional online survey to all physicians in the Division of General Internal Medicine and Clinical Innovation at NYULH, across 5 different practice settings. A total of 138 (out of 530) responded (26%).

Vaccine Lessens Incidence of Herpes Zoster Complications in Immuncompetent Older Adults

Vaccine Lessens Incidence of Herpes Zoster Complications in Immuncompetent Older Adults

Researchers reviewed clinical trial data to evaluate the efficacy of herpes zoster subunit vaccine in preventing complications, hospitalizations, and deaths.

1980 to 2014 Saw Decrease in US Mortality From Infectious Diseases

1980 to 2014 Saw Decrease in US Mortality From Infectious Diseases

There were declines in mortality from most categories of infectious diseases, with large differences among US counties. However, over this time there was an increase in mortality for diarrheal diseases.

Inactivity, Prolonged Sitting Tied to Urinary Tract Infections in Men

Inactivity, Prolonged Sitting Tied to Urinary Tract Infections in Men

Result supports the importance of both reducing sitting time and promoting physical activity for preventing lower urinary tract symptoms.

Rotavirus Vaccines Reduce Hospitalizations of Low Birth Weight Infants

Rotavirus Vaccines Reduce Hospitalizations of Low Birth Weight Infants

Rotavirus vaccines are effective in reducing rates of acute gastroenteritis and rotavirus hospitalizations among low birth weight and very low birth weight children.

Vaccine-Derived Immune Protection Against Mumps Wanes

Vaccine-Derived Immune Protection Against Mumps Wanes

Vaccine-derived immune protection against mumps wanes on average 27 years after vaccination.

Myopericarditis Risk in Adults Following Live Viral Vaccination Rare

Myopericarditis Risk in Adults Following Live Viral Vaccination Rare

Findings confirm that cardiovascular complications related to commonly-administered, live viral vaccination are rare in adults.

Measles Vaccination After Third Dose of DTP Vaccine May Improve Child Survival

Measles Vaccination After Third Dose of DTP Vaccine May Improve Child Survival

Measles vaccination, administered in the recommended sequence, is associated with improved child survival and may have contribute to the achievement of Millennium Development Goal 4.

Effect of Vaccine Antigen Exposure in First 23 Months of Life

Effect of Vaccine Antigen Exposure in First 23 Months of Life

The estimated cumulative vaccine antigen exposure through age 23 months does not differ significantly for children with vs those without hospital visits for infectious diseases not targeted by vaccines from age 24 to 47 months.

Risk of Infant Hospitalizations, Death Not Linked to Maternal Vaccination

Risk of Infant Hospitalizations, Death Not Linked to Maternal Vaccination

Maternal receipt of influenza and tetanus toxoid, reduced diphtheria toxoid, and Tdap vaccines is not associated with infant hospitalization or death.

Third Trimester Maternal Vaccination Against Pertussis Protective for Infants

Third Trimester Maternal Vaccination Against Pertussis Protective for Infants

Maternal vaccination against pertussis between 27 and 36 weeks of gestation was associated with a high percentage of newborns with protective pertussis antibody concentrations.

ACIP: New Recommendations for Herpes Zoster Vaccine Administration

ACIP: New Recommendations for Herpes Zoster Vaccine Administration

The Advisory Committee on Immunization Practices has provided 3 new recommendations to supplement its original 2008 report, as well as a cost-effectiveness analysis from the CDC.

Meningococcal Serogroup B Vaccine Safe, Effective Short-Term in Children, Adolescents

Meningococcal Serogroup B Vaccine Safe, Effective Short-Term in Children, Adolescents

In the overall comparative meta-analyses, the multicomponent meningococcal serogroup B vaccine had increased immunogenicity (short-term and persistent) compared with recombinant meningococcal serogroup B vaccine against strain NZ98/254.

ACIP: 2018 Immunization Schedule for Children, Adolescents Released

ACIP: 2018 Immunization Schedule for Children, Adolescents Released

The ACIP has released the 2018 Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger.

ACIP: 2018 Adult Immunization Schedule Now Available

ACIP: 2018 Adult Immunization Schedule Now Available

The ACIP has released the 2018 Recommended Immunization Schedule for Adults Aged 19 Years or Older.

Sign Up for Free e-newsletters